Why is Piramal Pharma falling/rising?

As of 17-Jun, Piramal Pharma Ltd's stock price is currently at 195.05, reflecting a decrease of 4.15, or 2.08%. The stock has been experiencing a downward trend, having fallen for the last two consecutive days with a total decline of 2.82%. It is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish sentiment. Additionally, there has been a significant drop in investor participation, with delivery volume decreasing by 60.28% compared to the 5-day average. Despite a strong long-term growth outlook, including a notable increase in operating profit and net sales, the stock's high Debt to EBITDA ratio of 3.21 times raises concerns about its ability to service debt, which may be contributing to the recent price decline.
In the broader market context, Piramal Pharma's short-term performance has lagged behind the benchmark, with a 1-week return of -5.48% compared to the Sensex's -0.98%. While the stock has outperformed the market over the past year with a return of 23.61%, the recent negative trends and high debt levels may be overshadowing its positive long-term growth indicators. The overall market sentiment appears to be cautious, particularly given the stock's recent struggles and declining investor interest, which could be influencing its current price movement.